Azienda Ospedaliera S. Camillo-Forlanini

Roma

0 studies enrolling now · 2 studies all time

What they study most

Graft Rejection, Multiple Sclerosis

Studies at this site

• Oral Cladribine in Early Multiple Sclerosis (MS) — Completed
• Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection — Completed